Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

71%

5 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

5(71.4%)

N/A

2(28.6%)

7Total

Phase 4(5)

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT01183182Phase 4Completed

Safety and Effectiveness Study for a Needle Guidance System in Lung Biopsies

Role: lead

NCT01148706Phase 4Completed

Effectiveness of ActiSight™ Needle Guidance System in Patients Undergoing CT-Guided Procedures

Role: lead

NCT01318473Phase 4Completed

The Use of the ActiSight™ Needle Guidance System in Patients Undergoing CT-Guided With Lesions Smaller Than 15 mm

Role: lead

NCT01040884Phase 4Completed

Safety And Accuracy Study Of The Actisight™ Needle Guidance System In Patients Undergoing CT-Guided Procedures

Role: lead

NCT01367392Phase 4Completed

Effectiveness and Safety of CT-guided Needle Placement in the Liver With the Aid of the ActiSight Needle Guidance System

Role: lead

NCT00814450Not ApplicableCompleted

Safety & Accuracy of the ActiSight Needle Guidance System in Percutaneous Chest Aspiration and Biopsy

Role: lead

NCT00819533Not ApplicableCompleted

Safety & Accuracy Study of the ActiSight Needle Guidance System in Patients Undergoing CT-Guided Percutaneous Chest Aspiration and Biopsy

Role: lead

All 7 trials loaded